Highlights and Quick Summary
- Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending March 31, 2022 was 4.67% (a -110.57% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -60.79%
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was -19.17% (a 172.69% increase from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was -7.03% (a -67.39% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was -21.56% (a 74.15% increase from previous year)
- Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending March 31, 2022 was -15.66% (a -18.31% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -508.88% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
| 31 Mar '22 | 31 Dec '21 | 30 Sep '21 | 30 Jun '21 |
|---|---|---|---|
| -15.66% | -19.17% | -0.47% | 3.83% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative (SG&A) Expenses Growth of Precigen, Inc.
Most recent Selling, General and Administrative (SG&A) Expenses Growthof PGEN including historical data for past 10 years.Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Precigen, Inc.
Precigen, Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 4.67% | – | – | – | – |
| 2021 | -44.2% | -16.36% | 11.91% | -12.96% | -19.17% |
| 2020 | 14.88% | 0.55% | -7.17% | -30.8% | -7.03% |
| 2019 | 112.76% | -42.68% | -44.08% | -21.86% | -21.56% |
| 2018 | -29.47% | -1.45% | -11.37% | 13.09% | -12.38% |
| 2017 | -50.73% | 16.16% | 28.35% | -18.06% | 0.84% |
| 2016 | 1.8% | 46.89% | 27.84% | 55.21% | 30.5% |
| 2015 | 75.63% | 54.98% | 53.9% | 102.63% | 71.34% |
| 2014 | 60.84% | 100.53% | 106.91% | 110.42% | 89.33% |
| 2013 | 143.7% | 16.96% | -51.67% | -52.48% | 35.03% |
| 2012 | – | – | -58.97% | -14.5% | 36.05% |
| 2011 | – | – | – | – | -26.5% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology